The new randomised controlled trial will explore the efficacy of Tarumase at higher concentration, in patients with venous ...

Wounds are more than just skin deep. They can affect every aspect of a person’s life, from mobility and independence to overall health and well-being. Whether you are dealing with ...

SolasCure has initiated a new Phase II clinical trial, CLEANVLU2, to further the development of its investigational product, ...

Medical honey proves effective against antibiotic-resistant bacteria, transforming wound care and offering hope in the fight ...

SolasCure, a Cambridge biotech developing a novel treatment to transform chronic wound healing, has initiated a new Phase II ...

Phase II clinical trial to determine the efficacy of Aurase Wound Gel at a higher concentration of the active enzyme Tarumase in venous leg ulcers SOLASCURE Ltd (SolasCure), a biotechnology company ...

UK biotechnology company SolasCure has commenced the randomised, controlled CLEANVLU2 Phase II trial of Aurase Wound Gel for ...

Phase II clinical trial to determine the efficacy of Aurase Wound ... leg ulcers SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing ...

In one advertisement, Fife flagged in 2023, a skin substitute representative whose company name has been redacted boasts of a ...

The pressure to improve outcomes may convince nursing homes to tap into new clinical resources, but not every pitch is worth ...

BioStem's Q4-2024 revenue expected to rise 794% YoY, with full-year net revenue increasing 1,702%. Read why I'm bullish on ...